Kelonia Therapeutics · 1 day ago
Scientist II/Sr. Scientist, In Vivo Pharmacology
Boston, MA
Full-time
Onsite
Mid, Senior LevelKelonia Therapeutics is a pioneering company in viral engineering and in vivo lentiviral gene and cell therapy. They are seeking a Scientist II/Sr. Scientist to lead in vivo murine model development, conduct preclinical studies, and mentor junior colleagues while contributing to innovative research in pharmacology.
BiotechnologyGeneticsHealth CareMedicalTherapeutics
Responsibilities
Lead in vivo murine model development and characterization for various programs
Design, plan, conduct, document, analyze and interpret preclinical in vivo studies in support of various programs
Work collaboratively to plan, execute, and analyze ex vivo characterization of multiple parameters such as bio-distribution and transduction efficiency
Prepare and present data and interpretations to cross-functional stakeholders
Help draft technical reports that document in vivo studies
Mentor and guide junior colleagues
Qualification
Required
Strong scientific expertise in Pharmacology or related discipline, PhD, and non-PhD candidates encouraged to apply (level based on experience)
In-depth experience in animal handling and drug administration including i.v./i.p./s.c. dosing, in-study blood sampling, IVIS imaging, necropsy, tissue harvest and processing
Understands and implements study protocols in accordance with regulatory requirements for compliance with IACUC guidelines
Demonstrated initiative in experimental design, troubleshooting, and performing robust data analysis
Excellent organizational and documentation skills
Adaptable analytical person with a get-it-done attitude
Ability to work collaboratively, meet deadlines, and prioritize and flexibly balance multiple workstreams
Preferred
Experience with humanized mouse models, engineered human T cells, and secondary ex vivo assays (eg. multicolor flow cytometry, PCR, MSD, IHC, ISH) is a plus
Benefits
Flexible Time Off
Competitive benefits package (health, commuter, and more)
Free parking
A state-of-the-art gym
A food hall
Company
Kelonia Therapeutics
Kelonia Therapeutics is developing a new wave of genetic medicines using its next-generation vivo gene delivery platform.
Founded in 2017
11-50 employees
H1B Sponsorship
Kelonia Therapeutics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (1)
2023 (8)
Funding
Current Stage
Early StageTotal Funding
$50M2022-04-28Series A· $50M
2020-01-01Seed
Leadership Team
Kevin Friedman
Chief Executive Officer
Recent News
2026-01-07
pharmaphorum
2025-11-27
Company data provided by crunchbase